In the wake of sweeping cuts at the FDA’s Office of Prescription Drug Promotion (OPDP), Sen. | In the wake of sweeping cuts ...

Although the FDA has rejected Stealth’s new drug application for Barth syndrome candidate elamipretide, the agency identified ...

Companies that interact with FDA are likely to find that the layoff of 3,500 employees on April 1, 2025, affects their dealings in a variety of ways. The cuts will likely have the greatest impact ...

The Department of Health and Human Services hasn't detailed exactly which positions or programs were cut in the mass layoffs. FDA Commissioner Marty Makary has repeatedly said that no FDA ...

Layoffs at HHS create opportunities for local biotech and life sciences companies to add talent and prevent what many fear ...

A federal judge Thursday extended a temporary restraining order blocking President Donald Trump's administration from ...

(Reuters) -Several leading public health, medical, civil rights, education and community organizations sent a letter to U.S.